Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly

References

• Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002 Dec 10;106(24):3006–3008.
   PubMed Web of Science ®Google Scholar
• Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2485–2491.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014 May 20;63(19):1972–1981.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015 Jun 20;385(9986):2477–2484.
   PubMed Web of Science ®Google Scholar
• Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014 May 8;370(19):1790–1798.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016 Apr 28;374(17):1609–1620.
   PubMed Web of Science ®Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017 Apr 6;376(14):1321–1331.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1695–1705.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019 May 2;380(18):1706–1715.
   PubMed Web of Science ®Google Scholar
• Durko AP, Head SJ, Pibarot P, et al. Characteristics of surgical prosthetic heart valves and problems around labelling: a document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) valve labelling task force. Eur J Cardio-thorac Surg. 2019 Jun 1;55(6):1025–1036.
   PubMed Web of Science ®Google Scholar
• Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017 Sep 21;38(36):2739–2791.
   PubMed Web of Science ®Google Scholar
• Wang TKM, Wang MTM, Gamble GD, et al. Performance of contemporary surgical risk scores for transcatheter aortic valve implantation: A meta-analysis. Int J Cardiol. 2017 Jun 1;236:350–355.
   PubMed Web of Science ®Google Scholar
• Tarantini G, Nai Fovino L, D’Errigo P, et al. Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: results from the OBSERVANT study. Catheter Cardiovasc Interv. 2020;95(6):E186–95.
   PubMed Web of Science ®Google Scholar
• Compagnone M, Moretti C, Marcelli C, et al. Surgical risk scores applied to transcatheter aortic valve implantation: friends or foes? Short-term and long-term outcomes from a single-center registry. J Invasive Cardiol. 2019 Oct;31(10):E282–88.
   PubMed Web of Science ®Google Scholar
• van Mourik MS, Vendrik J, Abdelghani M, et al. Guideline-defined futility or patient-reported outcomes to assess treatment success after TAVI: what to use? Results from a prospective cohort study with long-term follow-up. Open Heart. 2018;5(2):e000879.
   PubMed Web of Science ®Google Scholar
• Arnold SV, Reynolds MR, Lei Y, et al. Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation. 2014 Jun 24;129(25):2682–2690.
   PubMed Web of Science ®Google Scholar
• Arnold SV, Afilalo J, Spertus JA, et al. Prediction of Poor Outcome After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Oct 25;68(17):1868–1877.
   PubMed Web of Science ®Google Scholar
• Puri R, Iung B, Cohen DJ, et al. TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J. 2016 Jul 21;37(28):2217–2225.
   PubMed Web of Science ®Google Scholar
• Liao YB, He ZX, Zhao ZG, et al. The relationship between chronic obstructive pulmonary disease and transcatheter aortic valve implantation–A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016 Mar;87(Suppl 1):570–578..
   PubMedGoogle Scholar
• Chopard R, Meneveau N, Chocron S, et al. Impact of chronic obstructive pulmonary disease on valve academic research consortium-defined outcomes after transcatheter aortic valve implantation (from the FRANCE 2 Registry). Am J Cardiol. 2014 May 1;113(9):1543–1549.
   PubMed Web of Science ®Google Scholar
• Conrotto F, Salizzoni S, Andreis A, et al. Transcatheter aortic valve implantation in patients with advanced chronic kidney disease. Am J Cardiol. 2017 May 1;119(9):1438–1442.
   PubMed Web of Science ®Google Scholar
• Ferro CJ, Chue CD, de Belder MA, et al. Impact of renal function on survival after transcatheter aortic valve implantation (TAVI): an analysis of the UK TAVI registry. Heart. 2015 Apr;101(7):546–552.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014 Jun 10;129(23):2440–2492.
   PubMed Web of Science ®Google Scholar
• Afilalo J, Lauck S, Kim DH, et al. Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR study. J Am Coll Cardiol. 2017 Aug 8;70(6):689–700.
   PubMed Web of Science ®Google Scholar
• Lindman BR, Alexander KP, O’Gara PT, et al. Futility, benefit, and transcatheter aortic valve replacement. JACC Cardiovasc Interventions. 2014 7;Jul(7):707–716.
   Google Scholar
• Allen C, Patterson T, Redwood S, et al. Frailty in patients undergoing transcatheter aortic valve replacement: frequently measured, seldom managed. JACC Cardiovasc Interventions. 2020 Jan 27;13(2):232–234.
   PubMed Web of Science ®Google Scholar
• Schoenenberger AW, Stortecky S, Neumann S, et al. Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J. 2013 Mar;34(9):684–692.
   PubMed Web of Science ®Google Scholar
• Schoenenberger AW, Moser A, Bertschi D, et al. Improvement of risk prediction after transcatheter aortic valve replacement by combining frailty with conventional risk scores. JACC Cardiovasc Interventions. 2018 Feb 26;11(4):395–403.
   PubMed Web of Science ®Google Scholar
• Saia F, Moretti C, Dall’Ara G, et al. Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: a new paradigm for the heart team decision making. JGC. 2016 Sep;13(6):475–482.
   Google Scholar
• Saia F, Marrozzini C, Ciuca C, et al. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention. 2013 Apr 22;8(12):1388–1397.
   PubMed Web of Science ®Google Scholar
• Dall’Ara G, Tumscitz C, Grotti S, et al. Contemporary balloon aortic valvuloplasty: changing indications and refined technique. Catheter Cardiovasc Interv. 2020 Feb 25. DOI:10.1002/ccd.28807.
   PubMedGoogle Scholar
• Arsalan M, Khan S, Golman J, et al. Balloon aortic valvuloplasty to improve candidacy of patients evaluated for transcatheter aortic valve replacement. J Interv Cardiol. 2018 Feb;31(1):68–73.
   PubMed Web of Science ®Google Scholar
• Kawsara A, Alqahtani F, Eleid MF, et al. Balloon aortic valvuloplasty as a bridge to aortic valve replacement: a contemporary nationwide perspective. JACC Cardiovasc Interventions. 2020 Mar 9;13(5):583–591.
   PubMed Web of Science ®Google Scholar
• Awtry E, Davidoff R. Low-flow/low-gradient aortic stenosis. Circulation. 2011 Dec 6;124(23):e739–41.
   PubMed Web of Science ®Google Scholar
• Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003 Jul 22;108(3):319–324.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Grantham JA, Connolly HM, et al. Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation. 2002 Aug 13;106(7):809–813.
   PubMed Web of Science ®Google Scholar
• Monin JL, Monchi M, Gest V, et al. Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography. J Am Coll Cardiol. 2001 Jun 15;37(8):2101–2107.
   PubMed Web of Science ®Google Scholar
• Hachicha Z, Dumesnil JG, Bogaty P, et al. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007 Jun 5;115(22):2856–2864.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Gabella T, Nombela-Franco L, Auffret V, et al. Transcatheter aortic valve implantation in patients with paradoxical low-flow, low-gradient aortic stenosis. Am J Cardiol. 2018 Aug 15;122(4):625–632.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Alsidawi S, Bae R, et al. Changes in quality of life in patients with low-flow aortic stenosis undergoing transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 Feb 20. DOI:10.1002/ccd.28805.
   Google Scholar
• Clavel MA, Magne J, Pibarot P. Low-gradient aortic stenosis. Eur Heart J. 2016 Sep 7;37(34):2645–2657.
   PubMed Web of Science ®Google Scholar
• Longhi S, Lorenzini M, Gagliardi C, et al. Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2016 Mar;9(3):325–327.
   PubMed Web of Science ®Google Scholar
• Bourguignon T, El Khoury R, Candolfi P, et al. Very long-term outcomes of the carpentier-edwards perimount aortic valve in patients aged 60 or younger. Ann Thorac Surg. 2015 Sep;100(3):853–859.
   PubMed Web of Science ®Google Scholar
• Blackman DJ, Saraf S, MacCarthy PA, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol. 2019 Feb 12;73(5):537–545.
   PubMed Web of Science ®Google Scholar
• Nishida T, Tominaga R. A look at recent improvements in the durability of tissue valves. Gen Thorac Cardiovasc Surg. 2013 Apr;61(4):182–190.
   PubMedGoogle Scholar
• Gleason TG, Reardon MJ, Popma JJ, et al. 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol. 2018 Dec 4;72(22):2687–2696.
   PubMed Web of Science ®Google Scholar
• Sondergaard L, Ihlemann N, Capodanno D, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019 Feb 12;73(5):546–553.
   PubMed Web of Science ®Google Scholar
• Roberts WC, Janning KG, Ko JM, et al. Frequency of congenitally bicuspid aortic valves in patients >/=80 years of age undergoing aortic valve replacement for aortic stenosis (with or without aortic regurgitation) and implications for transcatheter aortic valve implantation. Am J Cardiol. 2012 Jun 1;109(11):1632–1636.
   PubMed Web of Science ®Google Scholar
• Rahhab Z, El Faquir N, Tchetche D, et al. Expanding the indications for transcatheter aortic valve implantation. Nat Rev Cardiol. 2020 Feb;17(2):75–84.
   PubMed Web of Science ®Google Scholar
• Mylotte D, Lefevre T, Sondergaard L, et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease. J Am Coll Cardiol. 2014 Dec 9;64(22):2330–2339.
   PubMed Web of Science ®Google Scholar
• Tchetche D, de Biase C, van Gils L, et al. Bicuspid aortic valve anatomy and relationship with devices: the BAVARD multicenter registry. Circ Cardiovasc Interventions. 2019 Jan;12(1):e007107.
   PubMed Web of Science ®Google Scholar
• Liu X, He Y, Zhu Q, et al. Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve. Catheter Cardiovasc Interv. 2018 Apr 1;91(5):986–994.
   PubMed Web of Science ®Google Scholar
• Yoon SH, Lefevre T, Ahn JM, et al. Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis. J Am Coll Cardiol. 2016 Sep 13;68(11):1195–1205.
   PubMed Web of Science ®Google Scholar
• Yoon SH, Sharma R, Chakravarty T, et al. Clinical outcomes and prognostic factors of transcatheter aortic valve implantation in bicuspid aortic valve patients. Ann Cardiothorac Surg. 2017 Sep;6(5):463–472.
   PubMed Web of Science ®Google Scholar
• Yoon SH, Bleiziffer S, De Backer O, et al. Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. J Am Coll Cardiol. 2017 May 30;69(21):2579–2589.
   PubMed Web of Science ®Google Scholar
• Perlman GY, Blanke P, Dvir D, et al. Bicuspid aortic valve stenosis: favorable early outcomes with a next-generation transcatheter heart valve in a multicenter study. JACC Cardiovasc Interventions. 2016 Apr 25;9(8):817–824.
   PubMed Web of Science ®Google Scholar
• Attinger-Toller A, Bhindi R, Perlman GY, et al. Mid-term outcome in patients with bicuspid aortic valve stenosis following transcatheter aortic valve replacement with a current generation device: A multicenter study. Catheter Cardiovasc Interv. 2020 May 1;95(6):1186–1192.
   PubMed Web of Science ®Google Scholar
• Kawamori H, Yoon SH, Chakravarty T, et al. Computed tomography characteristics of the aortic valve and the geometry of SAPIEN 3 transcatheter heart valve in patients with bicuspid aortic valve disease. Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1408–1418.
   PubMed Web of Science ®Google Scholar
• Al Emam AR, Chamsi-Pasha M, Pavlides G. Ostial coronary occlusion during TAVR in bicuspid aortic valve, should we redefine what is a safe ostial height? Int J Cardiol. 2016 Jun 1;212:288–289.
   PubMed Web of Science ®Google Scholar
• Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interventions. 2009 Sep;2(9):811–820.
   PubMed Web of Science ®Google Scholar
• Naqvi TZ. Echocardiography in transcatheter aortic valve implantation-Part 1-Transthoracic echocardiography. Echocardiography. 2018 Jul;35(7):1005–1019.
   PubMed Web of Science ®Google Scholar
• Naqvi TZ. Echocardiography in transcatheter aortic (Core)Valve implantation: part 2-Transesophageal echocardiography. Echocardiography. 2018 Jul;35(7):1020–1041.
   PubMed Web of Science ®Google Scholar
• de Brito FS Jr., Carvalho LA, Sarmento-Leite R, et al. Outcomes and predictors of mortality after transcatheter aortic valve implantation: results of the Brazilian registry. Catheter Cardiovasc Interv. 2015 Apr;85(5):E153–62.
   PubMed Web of Science ®Google Scholar
• Onishi T, Sengoku K, Ichibori Y, et al. The role of echocardiography in transcatheter aortic valve implantation. Cardiovasc Diagn Ther. 2018 Feb;8(1):3–17.
   PubMed Web of Science ®Google Scholar
• Hahn RT, Nicoara A, Kapadia S, et al. Echocardiographic imaging for transcatheter aortic valve replacement. J Am Soc Echocardiography. 2018 Apr;31(4):405–433.
   PubMed Web of Science ®Google Scholar
• Saia F, Palmerini T, Marcelli C, et al. Routine minimalist transcatheter aortic valve implantation with local anesthesia only. J Cardiovasc Med. 2020. DOI:10.2459/JCM.0000000000001030
   Google Scholar
• Scarsini R, De Maria GL, Joseph J, et al. Impact of complications during transfemoral transcatheter aortic valve replacement: how can they be avoided and managed? J Am Heart Assoc. 2019 Sep 17;8(18):e013801.
   PubMed Web of Science ®Google Scholar
• Genereux P, Webb JG, Svensson LG, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012 Sep 18;60(12):1043–1052.
   PubMed Web of Science ®Google Scholar
• Gilard M, Eltchaninoff H, Donzeau-Gouge P, et al. Late outcomes of transcatheter aortic valve replacement in high-risk patients: the FRANCE-2 registry. J Am Coll Cardiol. 2016 Oct 11;68(15):1637–1647.
   PubMed Web of Science ®Google Scholar
• Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data From the GARY registry. J Am Coll Cardiol. 2015 May 26;65(20):2173–2180.
   PubMed Web of Science ®Google Scholar
• D’Errigo P, Barbanti M, Santini F, et al. [Results of the OBSERVANT study: clinical characteristics and short-term outcome of the enrolled population treated with transcatheter versus surgical aortic valve implantation]. G Ital Cardiol. 2014 Mar;15(3):177–184.
   Google Scholar
• Ludman PF, Moat N, de Belder MA, et al. Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) registry, 2007 to 2012. Circulation. 2015 Mar 31;131(13):1181–1190.
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr., Brennan JM, Rumsfeld JS, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. Jama. 2015 Mar 10;313(10):1019–1028.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. Jama. 2013 Nov 20;310(19):2069–2077.
   PubMed Web of Science ®Google Scholar
• Biasco L, Ferrari E, Pedrazzini G, et al. Access Sites for TAVI: patient selection criteria, technical aspects, and outcomes. Front Cardiovasc Med. 2018;5:88.
   PubMed Web of Science ®Google Scholar
• Saia F, Gandolfo C, Palmerini T, et al. In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry. EuroIntervention. 2020 Feb 20;15(14):1240–1247.
   PubMed Web of Science ®Google Scholar
• Saia F Optimizing procedural outcomes. Cardiac Interventions Today; 2019 Sep - Oct.
   Google Scholar
• Seto AH, Abu-Fadel MS, Sparling JM, et al. Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc Interventions. 2010 Jul;3(7):751–758.
   PubMed Web of Science ®Google Scholar
• Burzotta F, Aurigemma C, Romagnoli E, et al. A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 Jan 11. DOI:10.1002/ccd.28697.
   Web of Science ®Google Scholar
• Saia F. Balloon aortic valvuloplasty today: dead man walking, die hard, or alive and kicking? JACC Cardiovasc Interventions. 2020 Mar 9;13(5):592–593.
   PubMed Web of Science ®Google Scholar
• Dato I, Burzotta F, Trani C, et al. Percutaneous management of vascular access in transfemoral transcatheter aortic valve implantation. World J Cardiol. 2014 Aug 26;6(8):836–846.
   PubMedGoogle Scholar
• Di Mario C, Goodwin M, Ristalli F, et al. A prospective registry of intravascular lithotripsy-enabled vascular access for transfemoral transcatheter aortic valve replacement. JACC Cardiovasc Interventions. 2019 Mar 11;12(5):502–504.
   PubMed Web of Science ®Google Scholar
• Blackstone EH, Suri RM, Rajeswaran J, et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation. 2015 Jun 2;131(22):1989–2000.
   PubMed Web of Science ®Google Scholar
• Arai T, Romano M, Lefevre T, et al. Direct comparison of feasibility and safety of transfemoral versus transaortic versus transapical transcatheter aortic valve replacement. JACC Cardiovasc Interventions. 2016 Nov 28;9(22):2320–2325.
   PubMed Web of Science ®Google Scholar
• Beurtheret S, Karam N, Resseguier N, et al. Femoral versus nonfemoral peripheral access for transcatheter aortic valve replacement. J Am Coll Cardiol. 2019 Dec 3;74(22):2728–2739.
   PubMed Web of Science ®Google Scholar
• Greenbaum AB, O’Neill WW, Paone G, et al. Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2795–2804.
   PubMed Web of Science ®Google Scholar
• Costa G, De Backer O, Pilgrim T, et al. Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry. EuroIntervention. 2020 Feb 7;15(15):e1319–e1324.
   PubMed Web of Science ®Google Scholar
• Genereux P, Head SJ, Hahn R, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles’ heel? A comprehensive review of the literature. J Am Coll Cardiol. 2013 Mar 19;61(11):1125–1136.
   PubMed Web of Science ®Google Scholar
• Said SM. Paravalvular leak, the Achilles’ heel of valve replacement: will transcatheter techniques be the answer? J Thorac Cardiovasc Surg. 2015 May;149(5):1276–1277.
   PubMed Web of Science ®Google Scholar
• Bauer F, Lemercier M, Zajarias A, et al. Immediate and long-term echocardiographic findings after transcatheter aortic valve implantation for the treatment of aortic stenosis: the Cribier-Edwards/Edwards-Sapien valve experience. J Am Soc Echocardiography. 2010 Apr;23(4):370–376..
   PubMed Web of Science ®Google Scholar
• Tarantini G, Gasparetto V, Napodano M, et al. Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications. Am J Cardiovasc Dis. 2011;1(3):312–320.
   PubMedGoogle Scholar
• Yared K, Garcia-Camarero T, Fernandez-Friera L, et al. Impact of aortic regurgitation after transcatheter aortic valve implantation: results from the REVIVAL trial. JACC Cardiovasc Imaging. 2012 May;5(5):469–477.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011 Jun;97(11):899–906.
   PubMed Web of Science ®Google Scholar
• Rajani R, Kakad M, Khawaja MZ, et al. Paravalvular regurgitation one year after transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2010 May 1;75(6):868–872.
   PubMed Web of Science ®Google Scholar
• Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) registry. J Am Coll Cardiol. 2011 Nov 8;58(20):2130–2138.
   PubMed Web of Science ®Google Scholar
• Cremer J, Heinemann MK, Mohr FW, et al. [Commentary by the German Society for Thoracic and Cardiovascular Surgery on the positions statement by the German Cardiology Society on quality criteria for transcatheter aortic valve implantation (TAVI)]. Thorac Cardiovasc Surg. 2014 Dec;62(8):639–644.
   PubMedGoogle Scholar
• Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011 Jan 25;123(3):299–308.
   PubMed Web of Science ®Google Scholar
• Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012 May 3;366(18):1686–1695.
   PubMed Web of Science ®Google Scholar
• Unbehaun A, Pasic M, Dreysse S, et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol. 2012 Jan 17;59(3):211–221.
   PubMed Web of Science ®Google Scholar
• Forrest JK, Kaple RK, Tang GHL, et al. Three generations of self-expanding transcatheter aortic valves: a report from the STS/ACC TVT registry. JACC Cardiovasc Interventions. 2020 Jan 27;13(2):170–179.
   PubMed Web of Science ®Google Scholar
• Solomonica A, Choudhury T, Bagur R. The mechanically expandable LOTUS Valve and LOTUS Edge transcatheter aortic valve systems. Expert Rev Med Devices. 2018 Nov;15(11):763–769.
   PubMed Web of Science ®Google Scholar
• Feldman TE, Reardon MJ, Rajagopal V, et al. Effect of mechanically expanded vs self-expanding transcatheter aortic valve replacement on mortality and major adverse clinical events in high-risk patients with aortic stenosis: the REPRISE III randomized clinical trial. Jama. 2018 Jan 2;319(1):27–37.
   PubMed Web of Science ®Google Scholar
• Cao D, Chiarito M, Pagnotta P, et al. Coronary revascularisation in transcatheter aortic valve implantation candidates: why, who, when? Interventional Cardiol. 2018 May;13(2):69–76.
   PubMedGoogle Scholar
• Van Mieghem NM, van der Boon RM, Faqiri E, et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc Interventions. 2013 Aug;6(8):867–875.
   PubMed Web of Science ®Google Scholar
• Khawaja MZ, Asrress KN, Haran H, et al. The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis. EuroIntervention. 2015 Aug;11(4):450–455.
   PubMed Web of Science ®Google Scholar
• Witberg G, Regev E, Chen S, et al. The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interventions. 2017 Jul 24;10(14):1428–1435.
   PubMed Web of Science ®Google Scholar
• Paradis JM, White JM, Genereux P, et al. Impact of coronary artery disease severity assessed with the SYNTAX score on outcomes following transcatheter aortic valve replacement. J Am Heart Assoc. 2017 Feb 20;6(2):e005070.
   PubMed Web of Science ®Google Scholar
• Stefanini GG, Stortecky S, Cao D, et al. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation. Eur Heart J. 2014 Oct 1;35(37):2530–2540.
   PubMed Web of Science ®Google Scholar
• Shamekhi J, Stundl A, Weber M, et al. Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation. Int J Cardiol. 2017 Oct 15;245:215–221.
   PubMed Web of Science ®Google Scholar
• Saia F, Palmerini T, Compagnone M, et al. Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2020 Jan;95(1):19–27.
   PubMed Web of Science ®Google Scholar
• Buzzatti N, Romano V, De Backer O, et al. Coronary access after repeated transcatheter aortic valve implantation: a glimpse into the future. JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 1):508–515.
   PubMed Web of Science ®Google Scholar
• Tarantini G, Fabris T, Cardaioli F, et al. Coronary access after transcatheter aortic valve replacement in patients with bicuspid aortic valve: lights and shades. JACC Cardiovasc Interventions. 2019 Jun 24;12(12):1190–1191.
   PubMed Web of Science ®Google Scholar
• Tarantini G, Fabris T, Nai Fovino L. TAVR-in-TAVR and coronary access: the importance of pre-procedural planning. EuroIntervention. 2020 Feb 25. DOI:10.4244/EIJ-D-19-01094
   Web of Science ®Google Scholar
• Abramowitz Y, Chakravarty T, Jilaihawi H, et al. Clinical impact of coronary protection during transcatheter aortic valve implantation: first reported series of patients. EuroIntervention. 2015 Sep;11(5):572–581.
   PubMed Web of Science ®Google Scholar
• Ribeiro HB, Rodes-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018 Feb 21;39(8):687–695.
   PubMed Web of Science ®Google Scholar
• Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. Jama. 2014 Jul;312(2):162–170.
   PubMed Web of Science ®Google Scholar
• Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J Am Coll Cardiol. 2018 Apr 10;71(14):1513–1524.
   PubMed Web of Science ®Google Scholar
• Palmerini T, Chakravarty T, Saia F, et al. Coronary protection to prevent coronary obstruction during transcatheter aortic valve replacement: a multicenter international registry. JACC Cardiovasc Interventions. 2020 Mar 23;13(6):739–747.
   PubMed Web of Science ®Google Scholar
• Blanke P, Soon J, Dvir D, et al. Computed tomography assessment for transcatheter aortic valve in valve implantation: the vancouver approach to predict anatomical risk for coronary obstruction and other considerations. J Cardiovasc Comput Tomogr. 2016 Nov - Dec;10(6):491–499.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Shimura T, Kano S, et al. Impact of preparatory coronary protection in patients at high anatomical risk of acute coronary obstruction during transcatheter aortic valve implantation. Int J Cardiol. 2016 Aug 15;217:58–63.
   PubMed Web of Science ®Google Scholar
• Chakravarty T, Jilaihawi H, Nakamura M, et al. Pre-emptive positioning of a coronary stent in the left anterior descending artery for left main protection: a prerequisite for transcatheter aortic valve-in-valve implantation for failing stentless bioprostheses? Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E630–6.
   PubMed Web of Science ®Google Scholar
• Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interventions. 2019 Jul 8;12(13):1240–1252.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010 Oct 21;363(17):1597–1607.
   PubMed Web of Science ®Google Scholar
• Eggebrecht H, Schmermund A, Voigtlander T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention. 2012 May 15;8(1):129–138.
   PubMed Web of Science ®Google Scholar
• Auffret V, Regueiro A, Del Trigo M, et al. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol. 2016 Aug 16;68(7):673–684.
   PubMed Web of Science ®Google Scholar
• Jochheim D, Zadrozny M, Ricard I, et al. Predictors of cerebrovascular events at mid-term after transcatheter aortic valve implantation - Results from EVERY-TAVI registry. Int J Cardiol. 2017 Oct 1;244:106–111.
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011 Jun 9;364(23):2187–2198.
   PubMed Web of Science ®Google Scholar
• Fairbairn TA, Mather AN, Bijsterveld P, et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart. 2012 Jan;98(1):18–23.
   PubMed Web of Science ®Google Scholar
• Bijuklic K, Haselbach T, Witt J, et al. Increased risk of cerebral embolization after implantation of a balloon-expandable aortic valve without prior balloon valvuloplasty. JACC Cardiovasc Interventions. 2015 Oct;8(12):1608–1613.
   PubMed Web of Science ®Google Scholar
• Fanning JP, Wesley AJ, Walters DL, et al. Neurological injury in intermediate-risk transcatheter aortic valve implantation. J Am Heart Assoc. 2016 Nov 15;5(11):e004203.
   PubMed Web of Science ®Google Scholar
• Ghanem A, Muller A, Sinning JM, et al. Prognostic value of cerebral injury following transfemoral aortic valve implantation. EuroIntervention. 2013 Mar;8(11):1296–1306.
   PubMed Web of Science ®Google Scholar
• Lansky AJ, Brown D, Pena C, et al. Neurologic complications of unprotected transcatheter aortic valve implantation (from the Neuro-TAVI Trial). Am J Cardiol. 2016 Nov 15;118(10):1519–1526.
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J, Dumont E, Boone RH, et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011 Jan 4;57(1):18–28.
   PubMed Web of Science ®Google Scholar
• Vlastra W, Vendrik J, Koch KT, et al. Cerebral protection devices during transcatheter aortic valve implantation. Trends Cardiovasc Med. 2018 Aug;28(6):412–418.
   PubMed Web of Science ®Google Scholar
• Kapadia SR, Kodali S, Makkar R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol. 2017 Jan 31;69(4):367–377.
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J, Kahlert P, Neumann FJ, et al. Feasibility and exploratory efficacy evaluation of the embrella embolic deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study. JACC Cardiovasc Interventions. 2014 Oct;7(10):1146–1155.
   PubMed Web of Science ®Google Scholar
• Wendt D, Kleinbongard P, Knipp S, et al. Intraaortic protection from embolization in patients undergoing transaortic transcatheter aortic valve implantation. Ann Thorac Surg. 2015 Aug;100(2):686–691.
   PubMed Web of Science ®Google Scholar
• Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur Heart J. 2015 Aug 14;36(31):2070–2078.
   PubMed Web of Science ®Google Scholar
• Seeger J, Gonska B, Otto M, et al. Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures. JACC Cardiovasc Interventions. 2017 Nov 27;10(22):2297–2303.
   PubMed Web of Science ®Google Scholar
• Seeger J, Kapadia SR, Kodali S, et al. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis. Eur Heart J. 2019 May 1;40(17):1334–1340.
   PubMed Web of Science ®Google Scholar
• Testa L, Latib A, Casenghi M, et al. Cerebral protection during transcatheter aortic valve implantation: an updated systematic review and meta-analysis. J Am Heart Assoc. 2018 May 4;7(10). DOI:10.1161/JAHA.117.008463.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. Jama. 2014 Apr 16;311(15):1503–1514.
   PubMed Web of Science ®Google Scholar
• van Rosendael PJ, Delgado V, Bax JJ. Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review. Eur Heart J. 2018 Jun 1;39(21):2003–2013.
   PubMed Web of Science ®Google Scholar
• Maeno Y, Abramowitz Y, Kawamori H, et al. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1139–1147.
   PubMed Web of Science ®Google Scholar
• Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol. 2009 Aug 25;54(9):764–776.
   PubMed Web of Science ®Google Scholar
• Nazif TM, Williams MR, Hahn RT, et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J. 2014 Jun 21;35(24):1599–1607.
   PubMed Web of Science ®Google Scholar
• Dizon JM, Nazif TM, Hess PL, et al. Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart. 2015 Oct;101(20):1665–1671.
   PubMed Web of Science ®Google Scholar
• Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014 Mar 18;129(11):1233–1243.
   PubMed Web of Science ®Google Scholar
• Johansen JB, Jorgensen OD, Moller M, et al. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J. 2011 Apr;32(8):991–998.
   PubMed Web of Science ®Google Scholar
• Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010 Apr;31(7):865–874.
   PubMed Web of Science ®Google Scholar
• Saia F, Latib A, Ciuca C, et al. Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement. Am Heart J. 2014 Nov;168(5):798–806.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Gulino S, Capranzano P, et al. Acute kidney injury with the renalguard system in patients undergoing transcatheter aortic valve replacement: the PROTECT-TAVI trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in transcatheter aortic valve implantation). JACC Cardiovasc Interventions. 2015 Oct;8(12):1595–1604.
   PubMed Web of Science ®Google Scholar
• Barbanti M, van Mourik MS, Spence MS, et al. Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial. EuroIntervention. 2019 Jun 20;15(2):147–154.
   PubMed Web of Science ®Google Scholar
• Wood DA, Lauck SB, Cairns JA, et al. The vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3M TAVR study. JACC Cardiovasc Interventions. 2019 Mar 11;12(5):459–469.
   PubMed Web of Science ®Google Scholar
• Saia F. Bring the old boys-and girls-Back home. Catheter Cardiovasc Interv. 2019 Sep 1;94(3):456–457.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana G, Jilaihawi H, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015 Nov 19;373(21):2015–2024.
   PubMed Web of Science ®Google Scholar
• Hansson NC, Grove EL, Andersen HR, et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol. 2016 Nov 8;68(19):2059–2069.
   PubMed Web of Science ®Google Scholar
• Pache G, Schoechlin S, Blanke P, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J. 2016 Jul 21;37(28):2263–2271.
   PubMed Web of Science ®Google Scholar
• Vranckx P, Windecker S, Welsh RC, et al. Thrombo-embolic prevention after transcatheter aortic valve implantation. Eur Heart J. 2017 Dec 1;38(45):3341–3350.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017 Jul 11;70(2):252–289.
   PubMed Web of Science ®Google Scholar
• Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020 Apr 30;382(18):1696–1707.
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J, Masson JB, Welsh RC, et al. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) randomized clinical trial. JACC Cardiovasc Interventions. 2017 Jul 10;10(13):1357–1365.
   PubMed Web of Science ®Google Scholar
• Jimenez Diaz VA, Tello-Montoliu A, Moreno R, et al. Assessment of platelet reactivity after transcatheter aortic valve replacement: the REAC-TAVI trial. JACC Cardiovasc Interventions. 2019 Jan 14;12(1):22–32.
   PubMed Web of Science ®Google Scholar
• Steffel J, Verhamme P, Potpara TS, et al. The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace. 2018 Aug 1;20(8):1231–1242.
   PubMed Web of Science ®Google Scholar
• Dangas GD, Tijssen JGP, Wohrle J, et al. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med. 2020 Jan 9;382(2):120–129.
   PubMed Web of Science ®Google Scholar